ProSci‘s roots lie in the research of Human Immunodefficiency Virus and working to develop a neutralizing vaccine against it. Below is an “abstract of abstracts” summarizing the research performed over the last several years that has built their business from
April 2016: The Antibody Update
This months ProSci news features a new study on broadly neutralizing antibodies long term treatment of HIV, where the first reported Zika Virus death in US territory occured, and a fully human polyclonal antibodies against Ebola-Z. Broadly Neutralizing Antibodies Prevent
Antibody Suppresses AIDS Virus
News from ProSci: Results from a new trial found that an “extremely potent” antibody can dramatically reduce the level of the HIV virus in a patient’s blood. An H9 T cell, blue, is shown infected with HIV, yellow. Researchers at